Anthem Biosciences Limited files SEBI Takeover Regulations disclosure

M&A / JV 16 Jun 2026 · Filed / open· ✓ Verified

Anthem Biosciences, a listed pharmaceutical company, has submitted a Regulation 31 disclosure to NSE under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Regulation 31(4) and 31(5) require disclosure by the acquirer within 2 working days of acquisition/crossing a slab of shares. The filing does not yet disclose the acquirer's identity, shareholding %, or offer price in the headline; these are detailed in the form DIS-4 appended to the NSE announcement.

Why it mattersFiling under Reg 31(4)–31(5) indicates acquisition of ≥5% stake (or crossing a slab threshold), obligating disclosure within 2 working days and potentially triggering open offer obligations if acquirer breaches 25% threshold; counsel must confirm whether acquirer is obliged to launch a mandatory offer.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals